Our Support for PROCURE and the Fight Against Prostate Cancer

Our Support for PROCURE and the Fight Against Prostate Cancer

We are delighted to share that Mantra Pharma proudly took part in the 2024 Noeudvembre campaign, organized by PROCURE. Held throughout November, this annual effort is dedicated to raising public awareness and funding critical research in the fight against prostate cancer, the most common cancer among men.

Lire la suite

A highly sought-after antibiotic now offered in a new strength

BROSSARD, QC, February 8, 2024 – At the height of the season when respiratory viruses are on the rise in the population, Mantra is solidifying its supply of an oral antibiotic whose shortage last year caused major issues for medical staff and parents of sick children.

Lire la suite

An innovative solution for optimal management of dyslipidemia now available

Brossard, January 5, 2024—People suffering from dyslipidemia, a frequently trivialized and even neglected silent disease, often underestimate its impact. Although drug therapy alternatives are available on the market, Mantra Pharma is pleased to inform people with dyslipidemia that a new natural solution is now available to help them optimize their lipid profile and improve their cardiovascular health. The product, named Cardiosmile, is now available behind the counter in Quebec pharmacies.

Lire la suite

Marcan Pharmaceuticals becomes shareholder of Mantra Pharma

Brossard, November 7, 2023 – Mantra Pharma, a company that develops and markets generic drugs and over-the-counter products, has taken another step to achieve its growth objectives by signing an agreement to bring in Marcan Pharmaceuticals, a Canadian pharmaceutical company, as a shareholder.

Lire la suite

Mantra Pharma maintains steady growth

BROSSARD, May 16, 2023— Mantra Pharma maintains impressive growth completing 39 product launches, including all strengths, in the past 16 months. A remarkable performance for a Quebec company competing in a market once dominated by major international pharmaceutical corporations.

Lire la suite

Expansion continues with the launch of 6 products, including M-Apixaban

BROSSARD, 21 September, 2022 - Since the beginning of 2022, Mantra Pharma has launched several new products, planning to offer no less than six new molecules by December, one of which is M-Apixaban. The Quebec-based pharmaceutical company is ready for a very busy fall and has increased its portfolio to nearly 100 products.

Lire la suite

Mantra Pharma opens its new distribution centre

LÉVIS, 10 January, 2021 - It is with great pride that Mantra Pharma’s Lévis team opened its new warehouse and business location The building already spreads out over 35,000 square feet and hosts 25 employees.

Lire la suite